Development of new AI-2 prodrugs and chemical probes to study the microbiota of...
Development of new AI-2 prodrugs and chemical probes to study the microbiota of the mammalian gastro-intestinal tract
Quorum sensing allows bacteria to synchronise and regulate their behaviours. Autoinducer-2 (AI-2) is a particularly relevant signaling molecule able to promote inter-species communication. In the mammalian gut microbiota, a therap...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2014-56568-R
DESARROLLO DE NUEVOS ANTIMICROBIANOS BASADOS EN EL ESTUDIO D...
Cerrado
PID2021-127318OB-I00
PLATAFORMA COMPUTACIONAL IMPULSADA POR INTELIGENCIA ARTIFICI...
133K€
Cerrado
BFU2008-00086
RESISTENCIA A COMPUESTOS ANTIMICROBIANOS VEGETALES EN BACTER...
182K€
Cerrado
BFU2008-00086
RESISTENCIA A COMPUESTOS ANTIMICROBIANOS VEGETALES EN BACTER...
182K€
Cerrado
PDC2021-121544-I00
DISEÑO DE UNA NUEVA CLASE DE ANTIMICROBIANOS CONTRA INFECCIO...
133K€
Cerrado
BIOFAGE
Interaction Dynamics of Bacterial Biofilms with Bacteriophag...
1M€
Cerrado
Información proyecto AI-2 Prodrugs
Duración del proyecto: 23 meses
Fecha Inicio: 2022-06-03
Fecha Fin: 2024-05-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Quorum sensing allows bacteria to synchronise and regulate their behaviours. Autoinducer-2 (AI-2) is a particularly relevant signaling molecule able to promote inter-species communication. In the mammalian gut microbiota, a therapeutically relevant niche, interference of AI-2-mediated signaling has been shown to influence the balance of the major phyla after antibiotic treatment. Still, the mechanisms involved in this process are not known. We propose to establish novel chemical and structural based approaches to decipher the mechanisms involved in the response of the gut microbiota to AI-2 and identify mechanisms that promote beneficial responses by the symbionts while inhibiting virulence in gut pathogens. For this, we will construct chemical tools that will function as AI-2 prodrugs to orally deliver intact AI-2 to the gut. AI-2 is a highly functionalised molecule, very reactive and unstable at high concentrations, thus a prodrug strategy will protect AI-2 until its release in the gut. To gain a molecular understanding involved in response to AI-2 we will identify AI-2 sensing mechanism (receptors) in commensal and pathogenic members of the microbiota belonging to the Clostridiaceae. For that, new AI-2 fluorescent probes will be designed and synthesised. The Clostridiaceae family are relevant members in the mammalian gut. These organisms include both beneficial as well as pathogenic members and we want to identify strategies to promote the beneficial response while inhibiting the pathogenic ones to promote a healthy microbiota community. Our hypothesis is that synthetic AI-2 can help in the recovery of a healthy bacterial phyla ratio after a distress, like antibiotic treatment.